Eurocityclinic LLC

Saint Petersburg 197022

0 studies enrolling now · 2 studies all time

What they study most

HER2 Exon 20 Mutation, Melanoma, Non-squamous NSCLC

Studies at this site

• A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma — Running, not enrolling
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed